https://cancer.ca/en/cancer-information/cancer-types/small-intestine/treatment/unresectable
Treatments for unresectable small intestine cancer | Canadian Cancer Society
Chemotherapy is the primary treatment for unresectable small intestine adenocarcinoma. Surgery and radiation may also be offered. In certain cases, targeted...
small intestine cancertreatments forunresectablecanadiansociety
https://www.spandidos-publications.com/10.3892/ol.2015.3589
Percutaneous biliary stenting combined with radiotherapy as a treatment for unresectable hilar...
Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.
https://www.fda.gov/drugs/resources-information-approved-drugs/fda-grants-accelerated-approval-lifileucel-unresectable-or-metastatic-melanoma
FDA grants accelerated approval to lifileucel for unresectable or metastatic melanoma | FDA
FDA grants accelerated approval to lifileucel for unresectable or metastatic melanoma
accelerated approvalfdagrants
https://www.spandidos-publications.com/10.3892/mco.2013.62
Analysis of the anatomic subsites, gender and age in unresectable advanced colorectal carcinomas in...
International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.
https://www.mayo.edu/research/clinical-trials/cls-20557344
Retrospective Chart Review of Real-World Treatment Outcomes of Locally Advanced Unresectable Or...
Learn more about services at Mayo Clinic.
retrospective chart reviewreal world
https://pmc.ncbi.nlm.nih.gov/articles/PMC10004388/
Outcomes of Intraductal Placement of Covered Metal Stents for Unresectable Distal Malignant Biliary...
Intraductal self-expandable metal stent (SEMS) placement may prolong stent patency by reducing duodenobiliary reflux. This study aimed to evaluate the efficacy...
https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2022.1096411/full
Frontiers | Case report and literature review: Conversion surgery for initially unresectable huge...
Background: Retroperitoneal liposarcoma (RPLS) is a rare malignancy that is notorious for recurrence. Surgical resection with clean margin is the current tre...
case reportliterature review
https://www.cochrane.org/ms/evidence/CD008533_routine-diversion-food-patients-unresectable-periampullary-cancers-without-obstruction-stomach
Routine diversion of food for patients with unresectable periampullary cancers without obstruction...
for patients
https://www.nice.org.uk/guidance/ta86/chapter/9-Sources-of-evidence-considered-by-the-Committee
9 Sources of evidence considered by the Committee | Imatinib for the treatment of unresectable...
Evidence-based recommendations on imatinib for treating unresectable or metastatic gastrointestinal stromal tumours in adults
by the
https://www.spandidos-publications.com/10.3892/ol.2026.15603?text=fulltext
Prognostic effect and prognostic factors of TACE for the treatment of unresectable hepatocellular...
Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.
for theprognosticeffectfactors
https://stanfordhealthcare.org/trials/p/NCT01055028.html
Paclitaxel + Bevacizumab (Avastin) for the Treatment of Metastatic or Unresectable Angiosarcoma
Stanford Health Care delivers the highest levels of care and compassion. SHC treats cancer, heart disease, brain disorders, primary care issues, and many more.
for thepaclitaxelbevacizumabavastin
https://www.mdpi.com/2072-6694/14/9/2232
Novel Carbon Ion and Proton Partial Irradiation of Recurrent Unresectable Bulky Tumors...
Background: We present the early results of a novel partial bulky-tumor irradiation using particles for patients with recurrent unresectable bulky tumors who...
https://www.mayo.edu/research/clinical-trials/cls-20582923
MEDI5752 In Combination With Carboplatin Plus Pemetrexed In Unresectable Pleural Mesothelioma -...
Learn more about services at Mayo Clinic.
combinationcarboplatinpluspemetrexedunresectable
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2024-09124
Datopotamab Deruxtecan and Trastuzumab Deruxtecan for the Treatment of HER2-Negative Unresectable,...
Datopotamab Deruxtecan and Trastuzumab Deruxtecan for the Treatment of HER2-Negative Unresectable, Locally Advanced or Metastatic Breast Cancer
datopotamab deruxtecanfor theher2 negativetrastuzumab
https://www.takeda.com/jp/newsroom/local-newsreleases/paradigm-2/
Data from the PARADIGM Trial in Chemotherapy-naive Japanese Patients with Unresectable Advanced...
Data from the PARADIGM Trial in Chemotherapy-naive Japanese Patients with Unresectable Advanced Recurrent Colorectal Cancer and Wild-type RAS Gene Presented at...
https://www.spandidos-publications.com/10.3892/mco.2022.2522
Novel approaches for the treatment of unresectable malignant pleural mesothelioma: A focus on...
International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.
https://www.mayo.edu/research/clinical-trials/cls-20457162
A Study to Evaluate the Effectiveness and Safety of Pemigatinib Versus Chemotherapy in Unresectable...
Learn more about services at Mayo Clinic.
https://www.biospace.com/istari-oncology-presents-positive-data-from-phase-1-study-of-pvsripo-in-patients-with-unresectable-treatment-refractory-melanoma-at-the-society-for-immunotherapy-of-cancer-sitc-35th-anniversary-annual-meeting
Istari Oncology Presents Positive Data from Phase 1 Study of PVSRIPO in Patients with Unresectable...
Nov 9, 2020 - Istari Oncology, Inc., a clinical-stage biotechnology company, today announced Phase 1 clinical data of its lead product candidate, PVSRIPO, for the treatment...
https://www.cochrane.org/hr/evidence/CD008976_gemcitabine-unresectable-advanced-or-metastatic-bladder-cancer
Gemcitabine for unresectable, advanced or metastatic bladder cancer | Cochrane
bladder cancergemcitabineunresectableadvancedmetastatic
https://www.roche.com/investors/updates/inv-update-2018-01-19
TECENTRIQ approved in Japan for the treatment of unresectable, advanced or recurrent NSCLC
https://www.mayo.edu/research/clinical-trials/cls-20504979
A Study to Evaluate Belinostat and Guadecitabine or ASTX727 to Treat Unresectable and Metastatic...
Learn more about services at Mayo Clinic.
a study
https://www.miragenews.com/imfinzi-combo-boosts-survival-in-unresectable-1649619/
Imfinzi Combo Boosts Survival in Unresectable Liver Cancer | Mirage News
Positive high-level results from the EMERALD-3 Phase III trial showed AstraZeneca's Imfinzi (durvalumab) in combination with Imjudo (tremelimumab
liver cancerimfinzicomboboostssurvival
https://www.fda.gov/drugs/resources-information-approved-drugs/fda-grants-accelerated-approval-fam-trastuzumab-deruxtecan-nxki-unresectable-or-metastatic-her2
FDA grants accelerated approval to fam-trastuzumab deruxtecan-nxki for unresectable or metastatic...
On April 5, 2024, the Food and Drug Administration granted accelerated approval to fam-trastuzumab deruxtecan-nxki (Enhertu, Daiichi Sankyo, Inc.) for adult...
fam trastuzumab deruxtecan
https://pmc.ncbi.nlm.nih.gov/articles/PMC4746088/
Contemporary Management of Borderline Resectable and Locally Advanced Unresectable Pancreatic...
This article reviews the literature and highlights the areas of controversy regarding management of borderline resectable pancreatic cancer (BRPC) and locally...
contemporary managementborderlineresectablelocallyadvanced
https://www.spandidos-publications.com/10.3892/ol.2026.15603
Prognostic effect and prognostic factors of TACE for the treatment of unresectable hepatocellular...
Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.
for theprognosticeffectfactors
https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2025.1530951/full
Frontiers | Efficacy and safety of D-TACE followed by D-RFA for unresectable large hepatocellular...
ObjectiveTo evaluate the safety and short-term clinical efficacy of drug-loaded polyvinyl alcohol microspheres transarterial chemoembolization (D-TACE) in th...
https://www.mdpi.com/2077-0383/13/9/2612
The Impact of Sequential Therapies after First-Line Systemic Therapies in Unresectable...
Background: The therapeutic options for hepatocellular carcinoma (HCC) have greatly expanded recently, and current first-line therapies include sorafenib,...
the impactfirst linesequentialtherapies
https://www.mayo.edu/research/clinical-trials/cls-20572259
A First-in-human Study of 3HP-2827 in Patients With Unresectable or Metastatic Solid Tumors With...
Learn more about services at Mayo Clinic.
https://www.mayo.edu/research/clinical-trials/cls-20522386?&p=1
Study Of Sacituzumab Govitecan (IMMU-132) In Metastatic Or Locally Advanced Unresectable Urothelial...
https://pmc.ncbi.nlm.nih.gov/articles/PMC6439847/
Efficacy and Safety of Avelumab Treatment in Patients With Advanced Unresectable Mesothelioma:...
Does avelumab have antitumor activity in patients with previously treated, unresectable malignant mesothelioma? In this phase 1b study, 53 patients with...
efficacy and safety
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-01092
Fulvestrant or Exemestane with or without Ribociclib in Patients with Recurrent, Unresectable, or...
Fulvestrant or Exemestane with or without Ribociclib in Patients with Recurrent, Unresectable, or Metastatic Hormone Receptor Positive, HER2 Negative Breast...
in patientsfulvestrantexemestanewithoutribociclib
https://www.mayo.edu/research/clinical-trials/cls-20548612?p=1
Radioembolization With Tremelimumab And Durvalumab For Locally Advanced Unresectable Or...
radioembolizationtremelimumabdurvalumablocallyadvanced
https://www.esmo.org/oncology-news/fda-approves-fam-trastuzumab-deruxtecan-nxki-with-pertuzumab-for-unresectable-or-metastatic-her2-positive-breast-cancer
FDA Approves fam-Trastuzumab Deruxtecan-nxki with Pertuzumab for Unresectable or Metastatic...
fam trastuzumab deruxtecan
https://www.fda.gov/drugs/drug-approvals-and-databases/fda-approves-fam-trastuzumab-deruxtecan-nxki-pertuzumab-unresectable-or-metastatic-her2-positive
FDA approves fam-trastuzumab deruxtecan-nxki with pertuzumab for unresectable or metastatic...
On December 15, 2025, the Food and Drug Administration approved fam-trastuzumab deruxtecan-nxki (Enhertu, Daiichi Sankyo, Inc.) in combination with pertuzumab...
fam trastuzumab deruxtecan
https://www.fda.gov/drugs/drug-approvals-and-databases/fda-approves-atezolizumab-pd-l1-positive-unresectable-locally-advanced-or-metastatic-triple-negative
FDA approves atezolizumab for PD-L1 positive unresectable locally advanced or metastatic...
On March 8, 2019, the Food and Drug Administration granted accelerated approval to atezolizumab (TECENTRIQ, Genentech Inc.) in combination with paclitaxel...
pd l1
https://www.nice.org.uk/guidance/ta86/chapter/5-Recommendations-for-further-research
5 Recommendations for further research | Imatinib for the treatment of unresectable and/or...
Evidence-based recommendations on imatinib for treating unresectable or metastatic gastrointestinal stromal tumours in adults
further research
https://www.scirp.org/journal/paperinformation?paperid=23462
Does Chemo-Radiation Therapy Influence Outcomes in Unresectable Locally Advanced State IV Rectal...
Introduction: The median survival for patients with stage IV rectal cancer is approximately 20 months. Therapy should focus not only on improving survival but...
https://www.cochrane.org/ru/evidence/CD004787_transarterial-chemoembolisation-unresectable-hepatocellular-carcinoma
Transarterial (chemo)embolisation for unresectable hepatocellular carcinoma | Cochrane
hepatocellular carcinomachemoembolisationunresectablecochrane
https://www.mountsinai.org/clinical-trials/study-evaluating-atezolizumab-with-without-bevacizumab-in-participants-with-unresectable-hepatocellular-carcinoma-child-pugh-b7-b8-cirrhosis
A Study Evaluating Atezolizumab, With or Without Bevacizumab, in Participants With Unresectable...
a studyevaluatingatezolizumab
https://www.mayo.edu/research/clinical-trials/cls-20548612
Radioembolization With Tremelimumab And Durvalumab For Locally Advanced Unresectable Or...
Learn more about services at Mayo Clinic.
radioembolizationtremelimumabdurvalumablocallyadvanced
https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2024.1478596/full
Frontiers | Sorafenib combined with tarexib for first-line treatment of unresectable hepatocellular...
BackgroundThis study aims to evaluate the safety efficacy of combining the PD-1 antibody Tirelizumab with Sorafenib in the treatment of advanced hepatocellul...
first line treatment
https://www.mayo.edu/research/clinical-trials/cls-20467886?&p=1
A Study To Evaluate M7824 With Concurrent Chemoradiation (CCRT) In Unresectable Stage III Non-small...
https://www.nice.org.uk/guidance/ta86/chapter/Update-information
Update information | Imatinib for the treatment of unresectable and/or metastatic gastro-intestinal...
Evidence-based recommendations on imatinib for treating unresectable or metastatic gastrointestinal stromal tumours in adults
https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2023.1113389/full
Frontiers | Toripalimab in combination with Anlotinib for unresectable hepatocellular carcinoma...
OBJECTIVE: Exposing tumor antigens to the immune system is the key to ensuring the efficacy of immunotherapy. SBRT is the main way to reveal the specifical a...
frontierstoripalimabcombinationanlotinibunresectable
https://pmc.ncbi.nlm.nih.gov/articles/PMC8057552/
Phase I trial of intratumoral PVSRIPO in patients with unresectable, treatment-refractory melanoma...
While programmed cell death protein 1 (PD-1) and programmed death-ligand 1 (PD-L1) antagonists have improved the prognosis for many patients with melanoma,...
phase i trial
https://www.nice.org.uk/guidance/ta410
Overview | Talimogene laherparepvec for treating unresectable metastatic melanoma | Guidance | NICE
Evidence-based recommendations on talimogene laherparepvec (Imlygic) for treating unresectable metastatic melanoma in adults when systemically administered...
talimogene laherparepvecmetastatic melanomaoverviewtreatingunresectable